STRO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sutro Biopharma Inc

Watchlist Manager

Watchlist

Price: 9.94 USD 4.52% Market Closed

Market Cap: $164.8m

	Sutro Biopharma Inc NASDAQ:STRO	US
	Microstrategy Inc BMV:MSTR	US
	Sunlands Technology Group F:S790	CN
V	Vinci SA F:SQUA	FR
	Time Out Group PLC F:05T	UK
	Bank of China Ltd F:W8VS	CN
	Tocvan Ventures Corp F:TV3	CA
S	SoftBank Group Corp XMUN:SFT	JP
W	Wells Fargo & Co XMUN:NWT	US
F	F5 Inc F:FFV	US
S	Stratasys Ltd F:SCY	US
C	China Travel International Investment Hong Kong Ltd F:CTI	HK
	Doximity Inc NYSE:DOCS	US
P	Prada SpA XMUN:PRP	IT
B	BioPlus Co Ltd KOSDAQ:099430	KR
O	Old National Bancorp F:ON1	US

Profitability Summary

Sutro Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-289%

Negative 3Y Average Operating Margin

-160%

Operating Margin is Increasing

-374% > -289%

Negative Net Margin

-395%

Negative 3Y Average Net Margin

-197%

Declining Net Margin

-355% > -395%

Negative Free Cash Flow Margin

-319%

Negative 3Y Average Free Cash Flow Margin

-180%

Free Cash Flow Margin is Increasing

-320% > -319%

Exceptional ROE

267%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-248%

Declining ROIC

-273% > -331%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.